| タイトル | Structural basis of CBP and EP300 interaction with kinase inhibitors |
|---|
| ジャーナル・号・ページ | To Be Published |
|---|
| 掲載日 | 2022年3月23日 (構造データの登録日) |
|---|
著者 | Schonbrunn, E. / Bikowitz, M. |
|---|
リンク | PubMedで検索 |
|---|
| 手法 | X線回折 |
|---|
| 解像度 | 1.45 - 2.004 Å |
|---|
| 構造データ | PDB-7ug5: Second bromodomain of BRD3 liganded with BMS-536924 手法: X-RAY DIFFRACTION / 解像度: 1.8 Å PDB-7uge: Bromodomain of CBP liganded with BMS-536924 手法: X-RAY DIFFRACTION / 解像度: 2.004 Å PDB-7ugf: First bromodomain of BRD4 liganded with BMS-536924 手法: X-RAY DIFFRACTION / 解像度: 1.45 Å PDB-7ugi: Bromodomain of EP300 liganded with BMS-536924 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-7ugl: Bromodomain of CBP liganded with BMS-536924 and SGC-CBP30 手法: X-RAY DIFFRACTION / 解像度: 1.5 Å PDB-8fup: Bromodomain of CBP liganded with BMS-536924 and CCS-1477 手法: X-RAY DIFFRACTION / 解像度: 1.7 Å |
|---|
| 化合物 | ChemComp-N6I: (3M)-4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-benzimidazol-2-yl]pyridin-2(1H)-one
ChemComp-PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL / 沈殿剤*YM
ChemComp-2LO: 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-benzimidazole
ChemComp-JHL: (6S)-1-[3,4-bis(fluoranyl)phenyl]-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl]piperidin-2-one
|
|---|
| 由来 | homo sapiens (ヒト)
|
|---|
キーワード | TRANSCRIPTION / bromodomain / small molecule ligand / complex / TRANSCRIPTION/INHIBITOR / TRANSCRIPTION-INHIBITOR complex |
|---|